KH902

· Chengdu Kanghong Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for KH902, covering 2013-03-01 to 2023-04-18. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD [Phase 3]

See pricing